| Ytd | 39.39% | |
| 1y | 77.12% |
| Open | 281.26 | Prev Close | 281.67 | Low | 276.01 | High | 283.00 | Mkt Cap | 13.39B |
| Vol | 1.48M | Avg Vol | 910.73K | EPS | -4.82 | P/E | N/A | Forward P/E | 21.92 |
| Beta | 1.41 | Short Ratio | 2.63 | Inst. Own | 123.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 262.62 | 200-d Avg | 204.41 | 1yr Est | 282.43 |
Investors looking for stocks in the Medical Services sector might want to consider either Progyny (P
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.57% on an annualize
Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference T
Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global H
Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and ra
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at t
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Morgan Stanley and Bair
Amundi trimmed its position in Charles River Laboratories International, Inc. (NYSE: CRL) by 46.7% d
IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight he
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Charles River's improving DSA demand and strategic investments support growth, but uneven recovery a
Charles River Laboratories International (NYSE: CRL - Get Free Report) and IB Acquisition (NASDAQ: I
According to prediction markets, final passage of the Clarity Act is not likely to happen until mid-
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.75% on an annualize
Great Lakes Advisors LLC purchased a new position in shares of Charles River Laboratories Internatio
Charles River's 33.3% monthly surge faces a higher bar as stronger bookings and guidance meet margin
CRL's shares have surged 88.6% in a year as DSA returns to organic growth, bookings climb and new te
On June 30, 2026, John Rogers (Trades, Portfolio), through Ariel Investment, LLC, executed a signifi
On June 30, 2026, John Rogers (Trades, Portfolio), through Ariel Investment, LLC, executed a reducti
On June 30, 2026, John Rogers (Trades, Portfolio), founder of Ariel Investment, LLC, increased the f
Collaboration leverages NGS technologies to accelerate high-quality vaccine development, support glo
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N
Wall Street analysts upgraded AVITA, Etsy, Unity, and raised target prices for these stocks. See wha
Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and i
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re
U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet
Wall Street analysts change outlook on top names. Complete view of analyst rating changes including
Top Wall Street analysts upgraded MITT & MFA. See ratings & price targets for these stocks.
Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J
Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shar
Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has signed definit
Wall Street pared early morning gains by midday Monday, as investor caution returned despite a tempo
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective an